WEBINAR:
Culturing to Support the Diagnosis of Tick-Borne Diseases
Culturing to Support the Diagnosis of Tick-Borne Diseases
OVERVIEW OF THE WEBINAR
Culture testing is widely considered to be the “gold standard” for diagnosis of tick-borne illnesses. For many years, tick-borne disease cultures were too expensive and tedious to be practical for laboratory use. Until now. After many years of research and development, IGeneX is pleased to introduce Culture-Enhanced PCR for all of the major tick-borne illnesses. IGeneX is currently the only lab that can culture all of the major tick-borne illnesses.
In this webinar, you will learn:
- The advantages of culture testing for tick-borne diseases
- Why including culturing is essential for a complete picture of your patient
- Why immune deficient patients may have a negative serology but a positive culture
- Why patients with inactive disease (or those on medication) may have a negative culture but a positive serology
- View actual patient data that will help you in your practice!
SPEAKER
Dr. Joseph J. Burrascano Jr.
IGeneX Consultant
Dr. Burrascano is a well-recognized specialist in the diagnosis and treatment of Lyme disease and associated infectious diseases. He has over 35 years of research in this field, and is also a founding member of ILADS and ILADS Educational Foundation.
WATCH VIDEO TO LEARN MORE
Who is the webinar for?
This webinar is perfect for those who want to take their tick-borne disease testing to the next level by including culturing in their testing mix.
Advantages of the IGeneX cePCR test
- Provides higher sensitivity than standard PCR testing
- The only 100% specific method for identification of a tick-borne disease
- Available for seven tick-borne diseases: Lyme disease, Tick-Borne Relapsing Fever, Bartonella, Babesia, Anaplasma, Ehrlichia, and Rickettsia
Download the slides here.
AVAILABLE CULTURE TEST PANELS
IGeneX offers a diverse range of Culture Enhanced PCR Testing panels tailored to specific requirements. Doctors and patients can opt for individual disease testing or select from our comprehensive test panels.
Borreliosis cePCR Test Panel
Includes two-week culture, plus PCR for Lyme and TBRF.
Co-infection cePCR Test Panel
Includes two-week culture, plus PCR for Babesia, Bartonella, HME, HGA, and Rickettsia.
Tick-Borne Disease cePCR Test Panel
Includes two-week culture, plus PCR for Lyme, TBRF, Babesia, Bartonella, HME,
HGA, and Rickettsia.
Please note: Medicare does not cover blood culturing. There is a $500 charge that is the responsibility of the patient for any cePCR tests. An ABN is required in advance for all Medicare beneficiaries.
